Oral COVID Pills by Merck Show Reduction in Hospitalization or Deaths (Molnupiriavir)
Merck shares interim phase II/III trial results for their oral COVID-19 prophylaxis, treatment, and prevention of spread pill called Molnupiriavir. Let's review the data.
https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/
https://clinicaltrials.gov/ct2/show/NCT04575597?term=molnupiravir&draw=2&rank=2
https://merckcovidresearch.com/
https://www.merck.com/news/merck-announces-supply-agreement-with-u-s-government-for-molnupiravir-an-investigational-oral-antiviral-candidate-for-treatment-of-mild-to-moderate-covid-19/
Buy me a coffee :-) https://www.buymeacoffee.com/DrMobeenSyed
Become my patron: https://www.patreon.com/mobeensyed?fan_landing=true
Looking to support my educational work? Donate here: https://paypal.me/mobeensyed?locale.x=en_US
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
#drbeen #koolbeens #COVID
0 Comments